Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease.
Mohammed Saeed Saad AlshahraniLaila Perlas AsontoMohamed M El TahanAmal H Al SulaibikhSukayna Z Al FarajAbdullah A Al MulhimMurad F Al AbbadSamar A Al NahhashMoath N AldarweeshAlaa M MahmoudNisreen AlmaghrabyMohammed A Al JumaanThamir O Al JunaidFaisal M Al HawajSamar AlKenanyOmaima F ElSayedHaitham M AbdelwahabMohamed M MoussaBader K AlossaimiShaikah K AlotaibiTalal M AlMutairiDuaa A AlSulaimanSaad D Al ShahraniDonia AlfarajWaleed AlhazzaniPublished in: Trials (2019)
Clinicaltrials.gov, NCT03431285 . Registered on 13 February 2018.